FDA Form 483 Issued to Eli Lilly Regarding Zyprexa

FDA Form 483 issued to Eli Lilly regarding Zyprexa

THE BASICS This is resulting from an inspection of the facility on South Delaware Street, Indianapolis, FEI #1819470, which began on September 11, 2023. FDA personnel spent five (5) days on-site. The 483 document is available for purchase/download here. The 483 contains five observations, ranging from failure to ensure prescribing HCPs are properly certified, to failure […]